{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1 is believed to function as a mitochondrial Ser/Thr protein kinase and protect SN dopaminergic neurons against various cellular stresses. Autosomal recessive inheritance indicates that PARK6 mutation-induced loss of PINK1 function is involved in the pathogenesis of PARK6.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving loss of PINK1 function leading to mitochondrial dysfunction and oxidative stress in dopaminergic neurons."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Confocal imaging of mitochondrial membrane potential (ΔΨ m ) and mitochondrial morphology, and assays for ROS generation were performed to investigate the physiological importance of PINK1 in maintaining mitochondrial function.",
          "judgment": "Yes",
          "reasoning": "The assays used effectively model the disease pathogenesis by assessing mitochondrial function and oxidative stress, which are central to the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study used wild-type and PINK1 knockout mice, and overexpressed wild-type and mutant PINK1 in cultured SN dopaminergic neurons. Controls included wild-type neurons and neurons overexpressing wild-type PINK1.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type and knockout) and replicates were used, and the assays are standard in the field.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "PARK6 mutant (G309D), (E417G) or (CΔ145) PINK1 failed to rescue mitochondrial dysfunction and inhibit oxidative stress in PINK1-deficient dopaminergic neurons.",
          "judgment": "Yes",
          "reasoning": "The study used known pathogenic variants as controls, demonstrating the assay's ability to distinguish between functional and non-functional PINK1 variants.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The study demonstrated that the G309D mutation leads to loss of PINK1 function in maintaining mitochondrial membrane potential, morphology, and inhibiting ROS formation.",
          "judgment": "Yes",
          "reasoning": "The evidence strongly supports the pathogenic nature of the G309D mutation due to its failure to rescue mitochondrial dysfunction compared to wild-type PINK1.",
          "next_step_or_outcome": "Final evidence strength assessment"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The G309D mutation in PINK1 is classified as pathogenic with very strong functional evidence (PS3_very_strong) due to its demonstrated loss of function in maintaining mitochondrial integrity and inhibiting oxidative stress, consistent with the disease mechanism of PARK6."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "E",
          "alt": "G",
          "position": "417"
        },
        "variant_string_id": "PINK1 E417G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1 is believed to function as a mitochondrial Ser/Thr protein kinase and protect SN dopaminergic neurons against various cellular stresses. Autosomal recessive inheritance indicates that PARK6 mutation-induced loss of PINK1 function is involved in the pathogenesis of PARK6.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving loss of PINK1 function leading to mitochondrial dysfunction and oxidative stress in dopaminergic neurons."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Confocal imaging of mitochondrial membrane potential (ΔΨ m ) and mitochondrial morphology, and assays for ROS generation were performed to investigate the physiological importance of PINK1 in maintaining mitochondrial function.",
          "judgment": "Yes",
          "reasoning": "The assays used effectively model the disease pathogenesis by assessing mitochondrial function and oxidative stress, which are central to the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study used wild-type and PINK1 knockout mice, and overexpressed wild-type and mutant PINK1 in cultured SN dopaminergic neurons. Controls included wild-type neurons and neurons overexpressing wild-type PINK1.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type and knockout) and replicates were used, and the assays are standard in the field.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "PARK6 mutant (G309D), (E417G) or (CΔ145) PINK1 failed to rescue mitochondrial dysfunction and inhibit oxidative stress in PINK1-deficient dopaminergic neurons.",
          "judgment": "Yes",
          "reasoning": "The study used known pathogenic variants as controls, demonstrating the assay's ability to distinguish between functional and non-functional PINK1 variants.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The study demonstrated that the E417G mutation leads to loss of PINK1 function in maintaining mitochondrial membrane potential, morphology, and inhibiting ROS formation.",
          "judgment": "Yes",
          "reasoning": "The evidence strongly supports the pathogenic nature of the E417G mutation due to its failure to rescue mitochondrial dysfunction compared to wild-type PINK1.",
          "next_step_or_outcome": "Final evidence strength assessment"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The E417G mutation in PINK1 is classified as pathogenic with very strong functional evidence (PS3_very_strong) due to its demonstrated loss of function in maintaining mitochondrial integrity and inhibiting oxidative stress, consistent with the disease mechanism of PARK6."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "C",
          "alt": "Δ",
          "position": "145"
        },
        "variant_string_id": "PINK1 CΔ145"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1 is believed to function as a mitochondrial Ser/Thr protein kinase and protect SN dopaminergic neurons against various cellular stresses. Autosomal recessive inheritance indicates that PARK6 mutation-induced loss of PINK1 function is involved in the pathogenesis of PARK6.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving loss of PINK1 function leading to mitochondrial dysfunction and oxidative stress in dopaminergic neurons."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Confocal imaging of mitochondrial membrane potential (ΔΨ m ) and mitochondrial morphology, and assays for ROS generation were performed to investigate the physiological importance of PINK1 in maintaining mitochondrial function.",
          "judgment": "Yes",
          "reasoning": "The assays used effectively model the disease pathogenesis by assessing mitochondrial function and oxidative stress, which are central to the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study used wild-type and PINK1 knockout mice, and overexpressed wild-type and mutant PINK1 in cultured SN dopaminergic neurons. Controls included wild-type neurons and neurons overexpressing wild-type PINK1.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type and knockout) and replicates were used, and the assays are standard in the field.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "PARK6 mutant (G309D), (E417G) or (CΔ145) PINK1 failed to rescue mitochondrial dysfunction and inhibit oxidative stress in PINK1-deficient dopaminergic neurons.",
          "judgment": "Yes",
          "reasoning": "The study used known pathogenic variants as controls, demonstrating the assay's ability to distinguish between functional and non-functional PINK1 variants.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The study demonstrated that the CΔ145 mutation leads to loss of PINK1 function in maintaining mitochondrial membrane potential, morphology, and inhibiting ROS formation.",
          "judgment": "Yes",
          "reasoning": "The evidence strongly supports the pathogenic nature of the CΔ145 mutation due to its failure to rescue mitochondrial dysfunction compared to wild-type PINK1.",
          "next_step_or_outcome": "Final evidence strength assessment"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The CΔ145 mutation in PINK1 is classified as pathogenic with very strong functional evidence (PS3_very_strong) due to its demonstrated loss of function in maintaining mitochondrial integrity and inhibiting oxidative stress, consistent with the disease mechanism of PARK6."
    }
  ]
}